Another vaccine may be on the way in the U.S., with advisors set to discuss 's protein-based jab this week - even as reports of the country wasting millions of shots due to lack of demand for them arise and the overall risk the virus poses to Americans every day continues to recede.This week, the Food ad Drug Administration's lead advisory panel, the Vaccines and Related Biological Products Advisory Committee (VRBPAC), will meet to discuss authorization for Novavax's shot, a jab many thought would be available over a year ago but was severely delayed due to reported supply issues.There is mounting evidence that adding another vaccine to the country's rotation may not be useful at the moment, though. Information obtained by NBC from the Centers for Disease Control and Prevention (CDC) finds that the country has discarded 82.1 million vaccine doses since December 2020, more than ten percent of the total vaccines purchased.
Load More
Load More